Skip to main content
. 2018 Jun 1;10(6):708. doi: 10.3390/nu10060708

Table 7.

Proteobacteria.

Reference [42] [43] [34] [35] [36] [37] [38] [39] [40] [41]
Taxa/Method YF PR Ill Miseq Ill Hiseq Ro
Unclassified <
Alpha-proteobacteria, Bradyrhizobiaceae, unspec <
OTU 469 (o1 = one OTU) >
Gamma-Proteobacteria, Enterobacteriaceae, Unspec < <
Gamma-Proteobacteria, Enterobacteriaceae, Escherichia/Shigella <
Gamma-Proteobacteria, Enterobacteriaceae, Proteus <
Gamma-Proteobacteria, Moraxellaceae, Unspec <
Gamma-Proteobacteria, Moraxellaceae, Acinetobacter <
Gamma-Proteobacteria, Pasteurellaceae, unspec. >

This table shows the significant relative changes in the Firmicutes phyla between PD patients (PD) and healthy controls (HC), that were assessed by the 10 summarized Parkinson’s disease studies. > symbolizes a higher abundance in HC when compared to PD; < symbolizes a lower abundance in HC when compared to PD; empty cells symbolize, that no significant change in PD compared to HC was found with the chosen methodological approach. The methods used by the studies are Yakult Intestinal Flora-SCAN (YF), 96-well block of the ABI PRISM 7900HT Sequence Detection System (PR), Illumina Miseq sequencing (Ill Miseq), Illumina Hiseq sequencing (Ill Hiseq), Roche 454 GS FLX Titanium sequencing (Ro).